PTC Shares Update on Regulatory Processes for Translarna in Europe and United States

December 15, 2023

On December 14, 2023, PTC Therapeutics shared an update to the Duchenne community about current regulatory processes for Translarna (ataluren) in Europe and the United States.

Please click here to view PTC’s letter.

Jett Foundation’s Silver Soirée
Thursday, June 11, 2026 | 5:30PM
Granite Links | Quincy, MA